{"id":"https://genegraph.clinicalgenome.org/r/32c72fac-7e83-4dce-ad75-053548125ae2v1.0","type":"EvidenceStrengthAssertion","dc:description":"ATP1A1 was first described in the context of autosomal dominant, axonal or intermediate Charcot-Marie-Tooth (CMT) disease, when Lassuthova et al. identified seven unrelated families with co-segregating or de-novo heterozygous point mutations (PMID: 29499166). Further intermediate neuropathy patients were reported by He et al. (PMID: 31373411) and Argente-Escrig et al. (PMID: 34323022), expanding the genotype spectrum to a number of 10 published pathogenic neuropathy variants as of August 2022. In parallel, ATP1A1 has been associated with renal hypomagnesemia and hypokalemia (PMID: 30388404), and several other variants have been reported in association with a complex phenotype involving distal weakness and spasticity, intellectual disability, hyperactivity, and seizures, partially with, but mainly without serum electrolyte disturbances (PMIDs: 35110381, 32277047, 33968856). ATP1A1 encodes the catalytic α1-subunit of the ATP-dependent sodium-potassium pump that is responsible for the stabilization of the electrochemical gradient over cell membranes. Sodium-potassium ATPases are ubiquitously expressed, however, the α1-subunit has a particularly high expression in the nervous system (PMID: 29499166). Functional studies on variants described in CMT patientsdemonstrated a reduced protein stability in transfected HeLa cells (PMID: 31373411) and a reduced cell viability under ATPase inhibitory ouabain treatment in transfected U2OS cells (PMID: 29499166). Similarly, two-electrode voltage clamp recordings showed reduced currents in transfected Xenopus cells compared to wildtype (PMID: 29499166). Based on gene and regional constraint (GnomAD), ATP1A1 is considered highly intolerant to haploinsufficiency, which is in accordance with the autosomal dominant inheritance. So far, it is not known how specific missense mutations cause one and not another associated phenotype. In a linear protein model, no regional clusters have been identified (PMID: 35110381). There is currently no further experimental evidence explaining how nerves are damaged specifically. It is possible that ATP1A1 mutation carriers with intellectual disability, spasticity, and/or seizures show (milder) signs of neuropathy as well, which might, however, retreat in the background of their more severe syndrome (PMID: 35110381, 32277047, 33968856). With a summed LOD score of 11.21 and the absence of such variants in healthy control collectives, we classify the gene-disease relationship of ATP1A1 and autosomal dominant, axonal and intermediate CMT as moderate. Further cases yet to be published and the expected replication over time will most likely increase the evidence score to a definitive level soon.","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/32c72fac-7e83-4dce-ad75-053548125ae2","GCISnapshot":"https://genegraph.clinicalgenome.org/r/65182954-6603-4880-85fa-352700bd784b","calculatedEvidenceStrength":"Moderate","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/65182954-6603-4880-85fa-352700bd784b_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10063","date":"2022-10-10T16:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/65182954-6603-4880-85fa-352700bd784b_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10063","date":"2022-10-10T19:20:05.333Z","role":"Publisher"}],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/65182954-6603-4880-85fa-352700bd784b_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/65182954-6603-4880-85fa-352700bd784b_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/26d41517-ece8-42ee-96e3-02580f2b0d85","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e07bac64-f40f-456e-b77b-c967d3d7b62b","type":"Finding","dc:description":"Distinct localization of α1 and α3 in myelinated axons. These are confocal images of teased fibers from an adult rat, immunostained with a mouse monoclonal antibody against α3 (XVIF9-G10; red), and a rabbit antiserum against α1 (NASE; green), as indicated. Two myelinated axons (1,3) have strong α3 staining (and weak α1 staining), and a myelinated axon (4) has strong α1 staining (and weak α3 staining). The incisures of myelin sheaths are α1-positive (inset). A Remak bundle (2) is α1-positive and α3-negative. Apposed arrowheads mark nodes of Ranvier. Scale bar: 10 μm.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29499166","rdfs:label":"Confocal microscopy of teased nerve fibers (rat)","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/65182954-6603-4880-85fa-352700bd784b_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9677fd97-e1ad-4946-a1d2-43bb57460d60","type":"EvidenceLine","dc:description":"Variant located in hot spot region","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9677fd97-e1ad-4946-a1d2-43bb57460d60_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29499166","allele":{"id":"https://genegraph.clinicalgenome.org/r/5b990917-c159-4fe9-847a-3a8236272d27","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000001.11:g.116395238G>A (GRCh38)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA341771615"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.25},{"id":"https://genegraph.clinicalgenome.org/r/4d89bac3-8d68-44b5-9083-213f7428920f","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4d89bac3-8d68-44b5-9083-213f7428920f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34323022","allele":{"id":"https://genegraph.clinicalgenome.org/r/94d90e58-7dfe-42c6-9cec-3fca0956c040","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000701.8(ATP1A1):c.1645G>A (p.Gly549Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/1299690"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/24fa0aec-d91b-4cc9-a916-d84ad4921c69","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/24fa0aec-d91b-4cc9-a916-d84ad4921c69_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Reduced protein half-life shown in overexpressed HeLa cells after CHX treatment with partial rescue after MG132 treatment (protease inhibitor)","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/24fa0aec-d91b-4cc9-a916-d84ad4921c69_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31373411","allele":{"id":"https://genegraph.clinicalgenome.org/r/a690aa37-1dce-40ed-b829-727c1c05683b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000001.11:g.116400917G>A (GRCh38)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA341774959"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/68ba94db-8dfe-4181-9f4e-e95a6fb5170c","type":"EvidenceLine","dc:description":"Variant affects hot spot region","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/68ba94db-8dfe-4181-9f4e-e95a6fb5170c_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Oubabin survival assay in transfected HEK cells","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/68ba94db-8dfe-4181-9f4e-e95a6fb5170c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29499166","allele":{"id":"https://genegraph.clinicalgenome.org/r/30c53157-f872-458f-9120-b41fec29e4cd","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000701.8(ATP1A1):c.1798C>A (p.Pro600Thr)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/545679"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.75},{"id":"https://genegraph.clinicalgenome.org/r/4307cef7-db3e-46f9-b660-c3316c8e584e","type":"EvidenceLine","dc:description":"Variant probably de novo, abundant functional evidence","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4307cef7-db3e-46f9-b660-c3316c8e584e_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"two electrodes voltage clamp in transfected Xenopus oocytes and ouabain survival assay in transfected U2OS cells","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/4307cef7-db3e-46f9-b660-c3316c8e584e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29499166","allele":{"id":"https://genegraph.clinicalgenome.org/r/0d706960-f32b-40cc-a590-116e4d3e9fdd","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000701.8(ATP1A1):c.2432A>C (p.Asp811Ala)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/545681"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/a8107b9c-a2ce-4edc-ae61-1a1de7bbdd7d","type":"EvidenceLine","dc:description":"Strong functional evidence","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a8107b9c-a2ce-4edc-ae61-1a1de7bbdd7d_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"two electrodes voltage clamp in transfected Xenopus oocytes and oubain survival assay to show haploinsufficiency","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/a8107b9c-a2ce-4edc-ae61-1a1de7bbdd7d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29499166","allele":{"id":"https://genegraph.clinicalgenome.org/r/c5cf2e37-a12b-44f2-9474-af40754ec6bb","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000701.8(ATP1A1):c.143T>G (p.Leu48Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/545677"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/65182954-6603-4880-85fa-352700bd784b_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7ebc6514-fb8c-4693-92fc-adfc4b866844_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29499166","rdfs:label":"Family 4","estimatedLodScore":1.2,"family":{"id":"https://genegraph.clinicalgenome.org/r/7ebc6514-fb8c-4693-92fc-adfc4b866844","type":"Family","rdfs:label":"Family 4","member":{"id":"https://genegraph.clinicalgenome.org/r/d771785f-b4d1-403e-ab83-99e340aa87f2","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29499166","rdfs:label":"V.1","allele":{"id":"https://genegraph.clinicalgenome.org/r/30c53157-f872-458f-9120-b41fec29e4cd"},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0001265","obo:HP_0001761","obo:HP_0009027","obo:HP_0000006","obo:HP_0003477"],"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/68ba94db-8dfe-4181-9f4e-e95a6fb5170c_variant_evidence_item"}}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":4,"phenotypes":["obo:HP_0003477","obo:HP_0001265","obo:HP_0009027","obo:HP_0001761","obo:HP_0000006"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/d771785f-b4d1-403e-ab83-99e340aa87f2"},"sequencingMethod":{"id":"cg:AllGenesSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/1d51cfb6-0c81-4fa4-9407-95bcb25882ea_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29499166","rdfs:label":"Family 6","estimatedLodScore":1.2,"family":{"id":"https://genegraph.clinicalgenome.org/r/1d51cfb6-0c81-4fa4-9407-95bcb25882ea","type":"Family","rdfs:label":"Family 6","member":{"id":"https://genegraph.clinicalgenome.org/r/a6bb3b25-a2f0-494b-b1c2-8269da49ba1f","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29499166","rdfs:label":"II.2","allele":{"id":"https://genegraph.clinicalgenome.org/r/3cce502e-41a6-47e5-ba76-30815e69ef40","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000001.11:g.116395250_116395251del (GRCh38)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2573320461"}},"firstTestingMethod":"Exome sequencing","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/59ba57ec-b60a-4e8c-b647-23ccdc66723a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29499166","allele":{"id":"https://genegraph.clinicalgenome.org/r/3cce502e-41a6-47e5-ba76-30815e69ef40"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":5,"phenotypes":["obo:HP_0009027","obo:HP_0001265","obo:HP_0000006","obo:HP_0001761","obo:HP_0003477"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/a6bb3b25-a2f0-494b-b1c2-8269da49ba1f"},"sequencingMethod":{"id":"cg:AllGenesSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/f0b45112-fbf9-46b1-83a3-8cfe2f0a1175_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31373411","rdfs:label":"He family 1","estimatedLodScore":1.2,"family":{"id":"https://genegraph.clinicalgenome.org/r/f0b45112-fbf9-46b1-83a3-8cfe2f0a1175","type":"Family","rdfs:label":"He family 1","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/03a8de1e-3108-40a5-a8e8-9e337f949048","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31373411","rdfs:label":"II.3","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":30,"allele":{"id":"https://genegraph.clinicalgenome.org/r/fdeb2e93-6493-4dfd-8f9c-5b1dcad61229","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000701.8(ATP1A1):c.620C>T (p.Ser207Phe)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA341842683"}},"detectionMethod":"P. 2, sections 2.2, 2.3ff","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0003477","obo:HP_0000006","obo:HP_0002936","obo:HP_0001761","obo:HP_0001265","obo:HP_0009027"],"previousTesting":true,"previousTestingDescription":"NGS panel","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/36c5265c-a800-46e2-ae10-47c4477666cf_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31373411","allele":{"id":"https://genegraph.clinicalgenome.org/r/fdeb2e93-6493-4dfd-8f9c-5b1dcad61229"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":5,"phenotypes":["obo:HP_0002936","obo:HP_0001761","obo:HP_0003477","obo:HP_0009027","obo:HP_0001265","obo:HP_0000006"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/03a8de1e-3108-40a5-a8e8-9e337f949048"},"sequencingMethod":{"id":"cg:AllGenesSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/beb76a6e-ce21-4ba6-a1d1-7bbe28ade60d_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29499166","rdfs:label":"Family 1","estimatedLodScore":3.91,"family":{"id":"https://genegraph.clinicalgenome.org/r/beb76a6e-ce21-4ba6-a1d1-7bbe28ade60d","type":"Family","rdfs:label":"Family 1","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/514c4541-a0e3-40ac-bf9e-1da54281bdb2","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29499166","rdfs:label":"III.1","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":25,"allele":{"id":"https://genegraph.clinicalgenome.org/r/c5cf2e37-a12b-44f2-9474-af40754ec6bb"},"ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0002936","obo:HP_0007141","obo:HP_0003477","obo:HP_0009027","obo:HP_0000006","obo:HP_0001761","obo:HP_0001265"],"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/a8107b9c-a2ce-4edc-ae61-1a1de7bbdd7d_variant_evidence_item"}}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":12,"phenotypes":["obo:HP_0003477","obo:HP_0007141","obo:HP_0000006","obo:HP_0002936","obo:HP_0009027","obo:HP_0001761","obo:HP_0001265"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/514c4541-a0e3-40ac-bf9e-1da54281bdb2"},"sequencingMethod":{"id":"cg:AllGenesSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/7cb4320d-4364-48ac-b2cd-d5c248ac716d_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29499166","rdfs:label":"Family 7","family":{"id":"https://genegraph.clinicalgenome.org/r/7cb4320d-4364-48ac-b2cd-d5c248ac716d","type":"Family","rdfs:label":"Family 7","member":{"id":"https://genegraph.clinicalgenome.org/r/a95d9475-134d-4f40-9305-7c29064afd2a","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29499166","rdfs:label":"II.2","allele":{"id":"https://genegraph.clinicalgenome.org/r/0d706960-f32b-40cc-a590-116e4d3e9fdd"},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0000006","obo:HP_0003477"],"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/4307cef7-db3e-46f9-b660-c3316c8e584e_variant_evidence_item"}}},"phenotypePositiveAllelePositive":1,"phenotypes":["obo:HP_0000006","obo:HP_0003477"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/a95d9475-134d-4f40-9305-7c29064afd2a"}},{"id":"https://genegraph.clinicalgenome.org/r/bbe06ade-6d35-4554-b525-eb893e16a519_proband_segregation","type":"FamilyCosegregation","dc:description":"3 segregations only, 2 individuals are twins","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29499166","rdfs:label":"Family 5","estimatedLodScore":0.9,"family":{"id":"https://genegraph.clinicalgenome.org/r/bbe06ade-6d35-4554-b525-eb893e16a519","type":"Family","rdfs:label":"Family 5","member":{"id":"https://genegraph.clinicalgenome.org/r/2fbccfd8-8605-477d-935a-a25ce5dae37d","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29499166","rdfs:label":"II.1","allele":{"id":"https://genegraph.clinicalgenome.org/r/5b990917-c159-4fe9-847a-3a8236272d27"},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0000006","obo:HP_0001761","obo:HP_0009027","obo:HP_0003477","obo:HP_0001265"],"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/9677fd97-e1ad-4946-a1d2-43bb57460d60_variant_evidence_item"}}},"meetsInclusionCriteria":false,"phenotypePositiveAllelePositive":5,"phenotypes":["obo:HP_0001265","obo:HP_0000006","obo:HP_0001761","obo:HP_0003477","obo:HP_0009027"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/2fbccfd8-8605-477d-935a-a25ce5dae37d"}},{"id":"https://genegraph.clinicalgenome.org/r/ad459dfe-cda2-4a31-8c5a-c3c4d6f98b7d_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29499166","rdfs:label":"Family 3","estimatedLodScore":0.6,"family":{"id":"https://genegraph.clinicalgenome.org/r/ad459dfe-cda2-4a31-8c5a-c3c4d6f98b7d","type":"Family","rdfs:label":"Family 3","member":{"id":"https://genegraph.clinicalgenome.org/r/a419ed60-34e4-4639-9254-97c1f22cb70d","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29499166","rdfs:label":"II.2","allele":{"id":"https://genegraph.clinicalgenome.org/r/349de6f0-7adc-408c-8471-8613f684763d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000701.8(ATP1A1):c.1775T>C (p.Ile592Thr)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/545680"}},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0000006","obo:HP_0003477"],"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/46c44fe5-183f-4224-b104-bbb86b9e4e6e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29499166","allele":{"id":"https://genegraph.clinicalgenome.org/r/349de6f0-7adc-408c-8471-8613f684763d"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":4,"phenotypes":["obo:HP_0003477","obo:HP_0000006"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/a419ed60-34e4-4639-9254-97c1f22cb70d"},"sequencingMethod":{"id":"cg:AllGenesSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/4675df8d-4ace-4c97-8258-d94090acd000_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29499166","rdfs:label":"Family 2","estimatedLodScore":2.71,"family":{"id":"https://genegraph.clinicalgenome.org/r/4675df8d-4ace-4c97-8258-d94090acd000","type":"Family","rdfs:label":"Family 2","member":{"id":"https://genegraph.clinicalgenome.org/r/e24ae6d2-a422-48a4-aadf-079bfdf02782","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29499166","rdfs:label":"IV.2","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":30,"allele":{"id":"https://genegraph.clinicalgenome.org/r/0fa2f680-be0e-4e33-abfa-250edf79550b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000701.8(ATP1A1):c.1798C>G (p.Pro600Ala)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA341771634"}},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0003477","obo:HP_0001761","obo:HP_0001265","obo:HP_0000006","obo:HP_0009027"],"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/636b41c8-34bb-4309-9e66-5344e48d01cc_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29499166","allele":{"id":"https://genegraph.clinicalgenome.org/r/0fa2f680-be0e-4e33-abfa-250edf79550b"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":5,"phenotypes":["obo:HP_0000006","obo:HP_0003477","obo:HP_0001761","obo:HP_0009027","obo:HP_0001265"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/e24ae6d2-a422-48a4-aadf-079bfdf02782"},"publishedLodScore":3.1,"sequencingMethod":{"id":"cg:AllGenesSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/593208f1-493e-474a-a627-0aca9b291450_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34323022","rdfs:label":"Argente family 1","estimatedLodScore":0.6,"family":{"id":"https://genegraph.clinicalgenome.org/r/593208f1-493e-474a-a627-0aca9b291450","type":"Family","rdfs:label":"Argente family 1","ethnicity":{"id":"cg:HispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/b247357a-eb17-4fb1-9ad2-68123777c1f1","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34323022","rdfs:label":"II.1","allele":{"id":"https://genegraph.clinicalgenome.org/r/94d90e58-7dfe-42c6-9cec-3fca0956c040"},"detectionMethod":"Sanger sequencing on an ABI Prism 3730xl (Applied Biosystems, Foster City, CA, USA) was performed to identify the disease-causing mutation in genetically diagnosed families. In all of the probands with demyelinating CMT, the CMT1A duplication was first analyzed by MLPA (Multiplex Ligation-dependent Probe Amplification) on a genetic analyzer ABI Prism 3130xl (Applied Biosystems, Foster City, CA, USA) and using the CMT1 SALSA kit P033-B4 (MRC-Holland, Amsterdam, the Netherlands). If a CMT1A duplication was ruled out, mutational screening of the SH3TC2, NDRG1, and HK1 genes was performed in demyelinating CMT patients of the Roma minority, as described previously.18 In the remaining undiagnosed index patients, an NGS-targeted custom panel was employed using the Sure Select QXT technology of Agilent technologies (Santa Clara, CA, USA). Any genetically undiagnosed patients after assessment with the gene panel subsequently underwent whole exome sequencing. In all cases, NGS libraries were sequenced using an Illumina system (San Diego, CA, USA). After variant annotation and filtering, variant classification was carried out based on the American College of Medical Genetics (ACMG) guidelines.19 All pathogenic variants were validated by Sanger sequencing.","ethnicity":{"id":"cg:HispanicOrLatino"},"firstTestingMethod":"Whole genome shotgun sequencing","phenotypes":["obo:HP_0000006","obo:HP_0007327"],"previousTesting":true,"previousTestingDescription":"PMP22 MLPA, Sanger screening for mutations in SH3TC2, NDRG1, and HK1","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/4d89bac3-8d68-44b5-9083-213f7428920f_variant_evidence_item"}}},"phenotypePositiveAllelePositive":3,"phenotypes":["obo:HP_0007327","obo:HP_0000006"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/b247357a-eb17-4fb1-9ad2-68123777c1f1"}},{"id":"https://genegraph.clinicalgenome.org/r/4c771b8d-2af5-49e9-b149-0738ea6c1a4b_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31373411","rdfs:label":"He family 2","family":{"id":"https://genegraph.clinicalgenome.org/r/4c771b8d-2af5-49e9-b149-0738ea6c1a4b","type":"Family","rdfs:label":"He family 2","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/87a6ab76-9976-4e5a-9ff9-7ddaa8744022","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31373411","rdfs:label":"II.1","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":23,"allele":{"id":"https://genegraph.clinicalgenome.org/r/a690aa37-1dce-40ed-b829-727c1c05683b"},"detectionMethod":"P. 2, sections 2.2ff","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Whole genome shotgun sequencing","phenotypes":["obo:HP_0001761","obo:HP_0003477","obo:HP_0002936","obo:HP_0000006","obo:HP_0009027","obo:HP_0001265"],"previousTesting":true,"previousTestingDescription":"NGS panel","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/24fa0aec-d91b-4cc9-a916-d84ad4921c69_variant_evidence_item"}}},"phenotypePositiveAllelePositive":1,"phenotypes":["obo:HP_0001761","obo:HP_0009027","obo:HP_0001265","obo:HP_0002936","obo:HP_0000006","obo:HP_0003477"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/87a6ab76-9976-4e5a-9ff9-7ddaa8744022"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":3},{"id":"https://genegraph.clinicalgenome.org/r/59ba57ec-b60a-4e8c-b647-23ccdc66723a","type":"EvidenceLine","dc:description":"Variant affects a hot spot region","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/59ba57ec-b60a-4e8c-b647-23ccdc66723a_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.25},{"id":"https://genegraph.clinicalgenome.org/r/36c5265c-a800-46e2-ae10-47c4477666cf","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/36c5265c-a800-46e2-ae10-47c4477666cf_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Reduced protein expression by western blot, as a sign of protein degradation, RNA levels unaffected (no NMD). Reduced protein half-life shown by CHX treatment, MG132 (proteasome inhibitor) led to increased protein levels by WB (overexpressing HeLa cells).","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/36c5265c-a800-46e2-ae10-47c4477666cf_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/46c44fe5-183f-4224-b104-bbb86b9e4e6e","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/46c44fe5-183f-4224-b104-bbb86b9e4e6e_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Ouabain survival assay in transfected U2OS cells","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/46c44fe5-183f-4224-b104-bbb86b9e4e6e_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/636b41c8-34bb-4309-9e66-5344e48d01cc","type":"EvidenceLine","dc:description":"Variant affects hot spot region","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/636b41c8-34bb-4309-9e66-5344e48d01cc_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"two electrodes voltage clamp in transfected Xenopus oocytes","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/636b41c8-34bb-4309-9e66-5344e48d01cc_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.75}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":9.1}],"evidenceStrength":"Moderate","sequence":5193,"specifiedBy":"GeneValidityCriteria9","strengthScore":9.6,"subject":{"id":"https://genegraph.clinicalgenome.org/r/odmHokxIw7w","type":"GeneValidityProposition","disease":"obo:MONDO_0054833","gene":"hgnc:799","modeOfInheritance":"obo:HP_0000006"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_65182954-6603-4880-85fa-352700bd784b-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}